SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-041077
Filing Date
2023-11-14
Accepted
2023-11-14 16:06:02
Documents
90
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 883033
2 ex3-1.htm EX-3.1 49552
3 ex10-8.htm EX-10.8 1350231
4 ex10-9.htm EX-10.9 1442169
5 ex31-1.htm EX-31.1 19167
6 ex31-2.htm EX-31.2 11937
7 ex32-1.htm EX-32.1 4459
8 ex32-2.htm EX-32.2 4403
9 GRAPHIC ex3-1_001.jpg GRAPHIC 5407
10 GRAPHIC ex10-8_001.jpg GRAPHIC 3109
11 GRAPHIC ex10-9_001.jpg GRAPHIC 10975
  Complete submission text file 0001493152-23-041077.txt   8238252

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE xtnt-20230930.xsd EX-101.SCH 43524
13 XBRL CALCULATION FILE xtnt-20230930_cal.xml EX-101.CAL 78354
14 XBRL DEFINITION FILE xtnt-20230930_def.xml EX-101.DEF 149607
15 XBRL LABEL FILE xtnt-20230930_lab.xml EX-101.LAB 329237
16 XBRL PRESENTATION FILE xtnt-20230930_pre.xml EX-101.PRE 269069
84 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 634471
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 231405939
SIC: 2836 Biological Products, (No Diagnostic Substances)